We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-12.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.1B
AUM Growth
-$2.55B
Cap. Flow
-$469M
Cap. Flow %
-3.86%
Top 10 Hldgs %
25.18%
Holding
858
New
52
Increased
315
Reduced
272
Closed
83

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$38.7M
2
AAPL icon
Apple
AAPL
+$27.7M
3
CRM icon
Salesforce
CRM
+$26.1M
4
VZ icon
Verizon
VZ
+$25.9M
5
PEP icon
PepsiCo
PEP
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 34.24%
2 Technology 24.24%
3 Financials 8.36%
4 Communication Services 6.82%
5 Industrials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAIL
126
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$23.6M 0.19%
376,267
-200,858
-35% -$12.4M
XYL icon
127
Xylem
XYL
$28.5B
$23.1M 0.19%
295,691
+8,989
+3% +$742K
C icon
128
Citigroup
C
$222B
$22.8M 0.19%
495,931
-1,129,276
-69% -$56.5M
MKC icon
129
McCormick & Company Non-Voting
MKC
$13.4B
$22.7M 0.19%
273,021
+29,614
+12% +$2.81M
IONS icon
130
Ionis Pharmaceuticals
IONS
$9.35B
$21.1M 0.17%
570,692
+71,145
+14% +$2.68M
BHVN
131
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$21M 0.17%
+144,428
New +$18.4M
ARVN icon
132
Arvinas
ARVN
$518M
$20.9M 0.17%
496,947
+6,240
+1% +$313K
BMY icon
133
Bristol-Myers Squibb
BMY
$127B
$20.9M 0.17%
271,517
-6,757
-2% -$515K
EOG icon
134
EOG Resources
EOG
$78B
$20.8M 0.17%
188,008
-2,937
-2% -$365K
POWI icon
135
Power Integrations
POWI
$3.54B
$20.7M 0.17%
275,895
-986
-0.4% -$80K
EA icon
136
Electronic Arts
EA
$52.4B
$20.6M 0.17%
169,448
-9,670
-5% -$1.23M
ASND icon
137
Ascendis Pharma A/S
ASND
$16.7B
$20.5M 0.17%
220,751
+56,433
+34% +$5.32M
MU icon
138
Micron Technology
MU
$1.04T
$20.5M 0.17%
370,542
+41,435
+13% +$2.81M
CYTK icon
139
Cytokinetics
CYTK
$11B
$20.4M 0.17%
520,476
-119,752
-19% -$4.82M
DFS
140
DELISTED
Discover Financial Services
DFS
$20.1M 0.17%
212,719
+169,882
+397% +$18.2M
FRC
141
DELISTED
First Republic Bank
FRC
$20M 0.16%
138,455
+21,717
+19% +$3.26M
VRNS icon
142
Varonis Systems
VRNS
$5.25B
$19.8M 0.16%
675,619
+12,996
+2% +$483K
FTNT icon
143
Fortinet
FTNT
$112B
$19.8M 0.16%
349,775
+26,765
+8% +$1.59M
DDOG icon
144
Datadog
DDOG
$87.9B
$19.7M 0.16%
207,336
+156,629
+309% +$17.2M
MRNA icon
145
Moderna
MRNA
$21.5B
$19.4M 0.16%
135,474
+5,224
+4% +$747K
ITW icon
146
Illinois Tool Works
ITW
$81.4B
$18.9M 0.16%
103,585
-42,960
-29% -$8.59M
ACET icon
147
Adicet Bio
ACET
$72.8M
$18.7M 0.15%
+80,224
New +$17.6M
CCK icon
148
Crown Holdings
CCK
$12.8B
$18.5M 0.15%
201,245
+72,382
+56% +$7.74M
CHD icon
149
Church & Dwight Co
CHD
$23.1B
$18.3M 0.15%
197,325
+141,407
+253% +$13.4M
EW icon
150
Edwards Lifesciences
EW
$47.6B
$18.1M 0.15%
189,853
+14,035
+8% +$1.45M

Similar funds

Candriam SCA's Q2 2022 Portfolio in Review

As of Q2 2022, Candriam SCA held 858 positions worth $12.1B, down 17% from $14.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $469M in Q2 2022, closing 83 positions and reducing 272 holdings. Its most notable exit was TriState Capital Holdings, Inc., an estimated $20.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Tenable Holdings worth $16.3M.

  • Candriam SCA's largest Q2 2022 buy was Tenable Holdings: 359,981 shares worth $16.3M.
  • Candriam SCA added most to Procter & Gamble in Q2 2022, an estimated $38.7M increase.
  • Candriam SCA's biggest Q2 2022 reduction was Microsoft, cutting an estimated $65.7M.
  • Candriam SCA fully exited TriState Capital Holdings, Inc. in Q2 2022, selling an estimated $20.9M.
  • Candriam SCA's ten largest holdings make up 25% of its $12.1B portfolio in Q2 2022.
  • Candriam SCA opened 52 new positions and closed 83 in Q2 2022.
  • Candriam SCA's portfolio value fell 17% quarter-over-quarter to $12.1B.

Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.